Skip to content

PRAX - Praxis Precision Medicines, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Praxis Precision Medicines Inc

PRAX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PRAXPraxis Precision Medicines Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $392.70
52-wk low: $37.19
Prev close: $221.76
Mkt cap: $10.18B
Beta: 2.78
P/S: 953.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.3B

P7
Point72
Steven Cohen · Q4 2025 13F
$145.1M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Aug 3, 2026

Earnings came in 20.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $10.2B

Valuation

P/S953.14
P/B8.04

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PRAX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $10.18B
Beta: 2.78

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

8.0x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-38.9%

$51.0M

position

MW

Marshall Wace

Q2 2026 13F

$45.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PRAX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$2.87+20.3%

-$3.60 expected

Next report

What the street expects next

EPS expected

-$3.51

-$4.23 to -$2.74

Revenue expected

$0.00

16 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

+0.51

Change in 30 days

-38.9%

ROA-25.7%

Growth

Beta2.78